What's going on in today's session
By Mill Chart
Last update: Apr 30, 2024
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| AKLI | 64.71% | AKILI INC's (NASDAQ:AKLI) shares rose 64.71% to $0.39 during Tuesday's session. A press release (Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results) was released earlier today. |
| CYCC | 47.79% | CYCLACEL PHARMACEUTICALS INC's (NASDAQ:CYCC) stock price increased by 47.79% to $2.01. Yesterday the company had a press release: Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules. |
| WGS | 47.55% | GENEDX HOLDINGS CORP's (NASDAQ:WGS) stock price is advancing with 47.55% to a price of $16.23. A press release (GeneDx Reports First Quarter 2024 Financial Results and Business Highlights) was released yesterday. |
| IMCC | 46.45% | IM CANNABIS CORP's (NASDAQ:IMCC) shares soared 46.45% to $0.82 during Tuesday's session. In the last month the share price dropped with 24.54%. |
| CGC | 40.63% | CANOPY GROWTH CORP's (NASDAQ:CGC) stock price increased by 40.63% to $11.7. Shareholders saw the stock price going 79.31% higher in the past 3 months. |
| SWVLW | 37.41% | PIVOTAL HOLDINGS CORP -CW27's (NASDAQ:SWVLW) stock price displayed strong growth, advancing 37.41% and reaching $0.02 during Tuesday's session. In the last 3 months the stock gained 47.0%. |
| ELYM | 36.65% | Investors celebrated as ELIEM THERAPEUTICS INC (NASDAQ:ELYM) experienced a 36.65% rise in its shares, closing at $6.86 during Tuesday's session. In the last month the stock gained 79.29%. |
| FLGC | 35.2% | Positive market sentiment drove FLORA GROWTH CORP's (NASDAQ:FLGC) stock price up by 35.2% to $1.73 during Tuesday's session. In the last month the stock lost 43.86%. |
| TLRY | 33.33% | TILRAY BRANDS INC's (NASDAQ:TLRY) stock price increased by 33.33% to $2.36. A press release (Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety) was released earlier today. |
| MAPSW | 30.6% | Investors witnessed a remarkable 30.6% rise in WM TECHNOLOGY INC-CW24's (NASDAQ:MAPSW) shares, which climbed to $0.07 during Tuesday's session. In the last 3 months the stock gained 37.2%. |
Our top gainers page will show you the full list.
Losers
| Ticker | Change | Comment |
|---|---|---|
| LICN | -34.98% | Investors witnessed a 34.98% decrease in LICHEN CHINA LTD- A's (NASDAQ:LICN) stock price, which closed at $1.32 during Tuesday's session. Shareholders saw the stock price going 86.24% higher in the past month. |
| BKKT | -29.47% | BAKKT HOLDINGS INC (NYSE:BKKT) encountered a 29.47% decrease in its shares, reaching $7.03 during Tuesday's session. The stock is trading 2.0K% higher than a month ago. |
| CHGG | -27.2% | During Tuesday's session, CHEGG INC's (NYSE:CHGG) shares took a tumble, falling 27.2% to $5.22. Yesterday the company had a press release: Chegg Announces Appointment of Nathan Schultz as Chief Executive Officer. |
| NRXP | -26.48% | Investors witnessed a 26.48% drop in NRX PHARMACEUTICALS INC's (NASDAQ:NRXP) stock price, which closed at $2.61 during Tuesday's session. In the last month the share price dropped with 32.38%. |
| BCLI | -23.93% | The market experienced a downward movement in BRAINSTORM CELL THERAPEUTICS's (NASDAQ:BCLI) stock price, closing at $0.41 with a 23.93% decrease during Tuesday's session. The stock is trading 27.07% lower than a month ago. |
| SAVAW | -23.53% | There was a downturn in CASSAVA SCIENCES INC-28's (NASDAQ:SAVAW) shares, as they experienced a 23.53% decline, closing at $0.29 during Tuesday's session. In the last month the share price dropped with 90.38%. |
| TCJH | -22.66% | Investors witnessed a 22.66% drop in TOP KINGWIN LTD-A's (NASDAQ:TCJH) stock price, which closed at $0.56 during Tuesday's session. Shareholders saw the stock price going 53.1% lower in the past month. |
| OPGN | -21.67% | Investors witnessed a 21.67% decrease in OPGEN INC's (NASDAQ:OPGN) stock price, which closed at $0.42 during Tuesday's session. The stock is trading 62.47% higher than 3 months ago. |
| ANVS | -20.05% | Investors witnessed a 20.05% drop in ANNOVIS BIO's (NYSE:ANVS) stock price, which closed at $5.82 during Tuesday's session. A press release (Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease) was released yesterday. |
| VAXX | -19.61% | Investors witnessed a 19.61% decrease in VAXXINITY INC-A's (NASDAQ:VAXX) stock price, which closed at $0.12 during Tuesday's session. Shareholders saw the stock price going 78.38% lower in the past month. |
For the full top loser list go to our top losers page.
NRX PHARMACEUTICALS INC
NASDAQ:NRXP (5/9/2024, 10:35:30 AM)
2.81
-0.01 (-0.35%)
NRXP News
a day ago - InvezzNRx Pharmaceuticals eyes first commercial revenue in 2024, announces breakthroughs in bi-annual milestone updateMichigan, United States, April 29th, 2024, FinanceWire NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and […]
a day ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...
2 days ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...
3 days ago - Get NewsFinal Clinical Trial Results Show Superior Safety and Efficacy for NRX-101; Plans to Seek Accelerated Approval for Bipolar Depression and Schizophrenia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
3 days ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar DepressionBoth drugs demonstrated > 50% response for treating depression. NRX-101 demonstrated a mean 76% reduction in symptoms of akathisia compared to lurasidone that...
8 days ago - ChartmillThese stocks are moving in today's pre-market sessionGet insights into the top gainers and losers of Wednesday's pre-market session.
9 days ago - ChartmillTuesday's after hours session: top gainers and losersWhich stocks are moving after the closing bell on Tuesday?
9 days ago - ChartmillWhat's going on in today's sessionWondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
9 days ago - ChartmillWhich stocks are moving on Tuesday?Which stocks are experiencing notable movement on Tuesday?
9 days ago - ChartmillWhich stocks are gapping on Tuesday?Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
9 days ago - NRx PharmaceuticalsNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar DepressionNRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75%...
21 days ago - InvestorPlaceWhy Is Bio-Path (BPTH) Stock Up 89% Today?Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.
